These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 15210795)

  • 1. Human complement factor I does not require cofactors for cleavage of synthetic substrates.
    Tsiftsoglou SA; Sim RB
    J Immunol; 2004 Jul; 173(1):367-75. PubMed ID: 15210795
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The catalytically active serine protease domain of human complement factor I.
    Tsiftsoglou SA; Willis AC; Li P; Chen X; Mitchell DA; Rao Z; Sim RB
    Biochemistry; 2005 Apr; 44(16):6239-49. PubMed ID: 15835912
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of proteolytic activity of complement factor I by pH: C3b/C4b receptor (CR1) and membrane cofactor protein (MCP) have different pH optima for factor I-mediated cleavage of C3b.
    Seya T; Okada M; Nishino H; Atkinson JP
    J Biochem; 1990 Feb; 107(2):310-5. PubMed ID: 2141838
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acquisition of complement inhibitor serine protease factor I and its cofactors C4b-binding protein and factor H by Prevotella intermedia.
    Malm S; Jusko M; Eick S; Potempa J; Riesbeck K; Blom AM
    PLoS One; 2012; 7(4):e34852. PubMed ID: 22514678
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complement factor I in health and disease.
    Nilsson SC; Sim RB; Lea SM; Fremeaux-Bacchi V; Blom AM
    Mol Immunol; 2011 Aug; 48(14):1611-20. PubMed ID: 21529951
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A mutation in factor I that is associated with atypical hemolytic uremic syndrome does not affect the function of factor I in complement regulation.
    Nilsson SC; Karpman D; Vaziri-Sani F; Kristoffersson AC; Salomon R; Provot F; Fremeaux-Bacchi V; Trouw LA; Blom AM
    Mol Immunol; 2007 Mar; 44(8):1835-44. PubMed ID: 17084897
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of binding sites on complement factor I using artificial N-linked glycosylation.
    Sanchez-Gallego JI; Groeneveld TW; Krentz S; Nilsson SC; Villoutreix BO; Blom AM
    J Biol Chem; 2012 Apr; 287(17):13572-83. PubMed ID: 22393059
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression and regulation of complement factors H and I in rat and human cells: some critical notes.
    Schlaf G; Demberg T; Beisel N; Schieferdecker HL; Götze O
    Mol Immunol; 2001 Aug; 38(2-3):231-9. PubMed ID: 11532284
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of binding sites on complement factor I that are required for its activity.
    Nilsson SC; Nita I; Månsson L; Groeneveld TW; Trouw LA; Villoutreix BO; Blom AM
    J Biol Chem; 2010 Feb; 285(9):6235-45. PubMed ID: 20044478
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phylogeny of C4b-C3b cleaving activity: similar fragmentation patterns of human C4b and C3b produced by lower animals.
    Kaidoh T; Gigli I
    J Immunol; 1987 Jul; 139(1):194-201. PubMed ID: 3295051
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enzymic assay of C3b receptor on intact cells and solubilized cells.
    Sim E; Sim RB
    Biochem J; 1983 Feb; 210(2):567-76. PubMed ID: 6222733
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preimplantation embryos cooperate with oviductal cells to produce embryotrophic inactivated complement-3b.
    Tse PK; Lee YL; Chow WN; Luk JM; Lee KF; Yeung WS
    Endocrinology; 2008 Mar; 149(3):1268-76. PubMed ID: 18039777
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mapping of the sites responsible for factor I-cofactor activity for cleavage of C3b and C4b on human C4b-binding protein (C4bp) by deletion mutagenesis.
    Fukui A; Yuasa-Nakagawa T; Murakami Y; Funami K; Kishi N; Matsuda T; Fujita T; Seya T; Nagasawa S
    J Biochem; 2002 Nov; 132(5):719-28. PubMed ID: 12417021
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-small cell lung cancer cells produce a functional set of complement factor I and its soluble cofactors.
    Okroj M; Hsu YF; Ajona D; Pio R; Blom AM
    Mol Immunol; 2008 Jan; 45(1):169-79. PubMed ID: 17548110
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factor I-dependent inactivation of human complement C4b of the classical pathway by C3b/C4b receptor (CR1, CD35) and membrane cofactor protein (MCP, CD46).
    Masaki T; Matsumoto M; Nakanishi I; Yasuda R; Seya T
    J Biochem; 1992 May; 111(5):573-8. PubMed ID: 1386357
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural basis for complement factor I control and its disease-associated sequence polymorphisms.
    Roversi P; Johnson S; Caesar JJ; McLean F; Leath KJ; Tsiftsoglou SA; Morgan BP; Harris CL; Sim RB; Lea SM
    Proc Natl Acad Sci U S A; 2011 Aug; 108(31):12839-44. PubMed ID: 21768352
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular characterization and expression analysis of the complement factor I (CpFI) in the whitespotted bamboo shark (Chiloscyllium plagiosum).
    Wang Y; Chen B; Ke Y; Wang C; Ye B
    Fish Shellfish Immunol; 2014 Oct; 40(2):414-23. PubMed ID: 25108086
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulator-dependent mechanisms of C3b processing by factor I allow differentiation of immune responses.
    Xue X; Wu J; Ricklin D; Forneris F; Di Crescenzio P; Schmidt CQ; Granneman J; Sharp TH; Lambris JD; Gros P
    Nat Struct Mol Biol; 2017 Aug; 24(8):643-651. PubMed ID: 28671664
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phylogeny of regulatory proteins of the complement system. Isolation and characterization of a C4b/C3b inhibitor and a cofactor from sand bass plasma.
    Kaidoh T; Gigli I
    J Immunol; 1989 Mar; 142(5):1605-13. PubMed ID: 2918226
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutations in complement factor I as found in atypical hemolytic uremic syndrome lead to either altered secretion or altered function of factor I.
    Nilsson SC; Kalchishkova N; Trouw LA; Fremeaux-Bacchi V; Villoutreix BO; Blom AM
    Eur J Immunol; 2010 Jan; 40(1):172-85. PubMed ID: 19877009
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.